Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in Urol Int

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    November 2018
  1. FERRO M, Musi G, Serino A, Cozzi G, et al
    Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.
    Urol Int. 2018 Nov 8:1-8. doi: 10.1159/000494259.
    PubMed     Text format     Abstract available


    October 2018
  2. MIYOSHI Y, Ohtaka M, Kawahara T, Ohtake S, et al
    Prediction of Time to Castration-Resistant Prostate Cancer Using Low-Molecular-Weight Protein Tyrosine Phosphatase Expression for Men with Metastatic Hormone-Naive Prostate Cancer.
    Urol Int. 2018 Oct 16:1-6. doi: 10.1159/000493324.
    PubMed     Text format     Abstract available


    September 2018
  3. KIM SJ, Lee SW, Ha HK
    Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Me
    Urol Int. 2018 Sep 28:1-10. doi: 10.1159/000493169.
    PubMed     Text format     Abstract available


  4. ROSENHAMMER B, Lausenmeyer EM, Mayr R, Burger M, et al
    Holmium Laser Enucleation of the Prostate Provides Similar Incidental Prostate Cancer Detection Rates as Open Prostatectomy: A Matched Pair Analysis.
    Urol Int. 2018 Sep 20:1-5. doi: 10.1159/000492923.
    PubMed     Text format     Abstract available


    July 2018
  5. PORCARO AB, Tafuri A, Sebben M, Corsi P, et al
    Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
    Urol Int. 2018;101:1-9.
    PubMed     Text format     Abstract available


    June 2018
  6. DARR C, Krafft U, Hadaschik B, Tschirdewahn S, et al
    The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer.
    Urol Int. 2018 Jun 27:1-9. doi: 10.1159/000489891.
    PubMed     Text format     Abstract available


    May 2018
  7. LUZZAGO S, Musi G, Catellani M, Russo A, et al
    Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.
    Urol Int. 2018 May 7:1-9. doi: 10.1159/000488772.
    PubMed     Text format     Abstract available


    April 2018
  8. PORCARO AB, Tafuri A, Novella G, Sebben M, et al
    Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set.
    Urol Int. 2018 Apr 19. pii: 000488882. doi: 10.1159/000488882.
    PubMed     Text format     Abstract available


    March 2018
  9. BRUENDL J, Rothbauer C, Ludwig B, Dotzler B, et al
    Accordance of Online Health Information on Prostate Cancer with the European Association of Urology Guidelines.
    Urol Int. 2018 Mar 7. pii: 000487146. doi: 10.1159/000487146.
    PubMed     Text format     Abstract available


    January 2018
  10. BORKOWETZ A, Renner T, Platzek I, Toma M, et al
    Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy.
    Urol Int. 2018 Jan 16. pii: 000486041. doi: 10.1159/000486041.
    PubMed     Text format     Abstract available


  11. TINAY I, Aslan G, Kural AR, Ozen H, et al
    Pathologic Outcomes of Candidates for Active Surveillance Undergoing Radical Prostatectomy: Results from a Contemporary Turkish Patient Cohort.
    Urol Int. 2018;100:43-49.
    PubMed     Text format     Abstract available


  12. AL-BAYATI M, Grueneisen J, Lutje S, Sawicki LM, et al
    Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.
    Urol Int. 2018;100:164-171.
    PubMed     Text format     Abstract available


  13. SANCHIS-BONET A, Barrionuevo-Gonzalez M, Bajo-Chueca A, Morales-Palacios N, et al
    Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?
    Urol Int. 2018;100:146-154.
    PubMed     Text format     Abstract available


    December 2017
  14. OLIVER T, Wilson P, Ansell W, Philp T, et al
    A Prospective Audit of Intermittent Anti-Androgen verses Pituitary Blockade Suggests a Bipolar Androgen Type Strategy May Be Safe in Untreated Prostate Cancer.
    Urol Int. 2017 Dec 22. pii: 000485255. doi: 10.1159/000485255.
    PubMed     Text format     Abstract available


  15. ALBKRI A, Girier D, Mestre A, Costa P, et al
    Urinary Incontinence, Patient Satisfaction, and Decisional Regret after Prostate Cancer Treatment: A French National Study.
    Urol Int. 2017;100:49-55.
    PubMed     Text format     Abstract available


  16. OHLMANN CH, Gross-Langenhoff M
    Efficacy and Tolerability of Leuprorelin Acetate (Eligard(R)) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3- or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer.
    Urol Int. 2017 Dec 1. pii: 000479187. doi: 10.1159/000479187.
    PubMed     Text format     Abstract available


    November 2017
  17. HAMMERER PG, Wirth MP
    Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis.
    Urol Int. 2017 Nov 25. pii: 000479434. doi: 10.1159/000479434.
    PubMed     Text format     Abstract available


  18. ARTIBANI W, Porcaro AB, De Marco V, Cerruto MA, et al
    Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
    Urol Int. 2017 Nov 21. doi: 10.1159/000481438.
    PubMed     Text format     Abstract available


    October 2017
  19. TANG Y, Liu Z, Tang L, Zhang R, et al
    Significance of MRI/Transrectal Ultrasound Fusion Three-Dimensional Model-Guided, Targeted Biopsy Based on Transrectal Ultrasound-Guided Systematic Biopsy in Prostate Cancer Detection: A Systematic Review and Meta-Analysis.
    Urol Int. 2017 Oct 30. doi: 10.1159/000484144.
    PubMed     Text format     Abstract available


  20. YOO S, You D, Kim YS, Hong JH, et al
    Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
    Urol Int. 2017 Oct 12. doi: 10.1159/000481265.
    PubMed     Text format     Abstract available


    September 2017
  21. ZAPALA P, Dybowski B, Poletajew S, Radziszewski P, et al
    What Can Be Expected from Prostate Cancer Biomarkers? A Clinical Perspective.
    Urol Int. 2017 Sep 15. doi: 10.1159/000479982.
    PubMed     Text format     Abstract available


    July 2017
  22. VON HARDENBERG J, Schwartz M, Werner T, Fuxius S, et al
    Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review.
    Urol Int. 2017 Jul 13. doi: 10.1159/000477943.
    PubMed     Text format     Abstract available


  23. FAHMY O, Khairul-Asri MG, Hadi SHSM, Gakis G, et al
    The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2017 Jul 4. doi: 10.1159/000478789.
    PubMed     Text format     Abstract available


    June 2017
  24. BOESEN L, Norgaard N, Logager V, Balslev I, et al
    A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
    Urol Int. 2017 Jun 27. doi: 10.1159/000477214.
    PubMed     Text format     Abstract available


  25. MIYOSHI Y, Yoneyama S, Kawahara T, Hattori Y, et al
    Prediction of Time to Castration-Resistant Prostate Cancer Using Bone Scan Index in Men with Metastatic Hormone-Sensitive Prostate Cancer.
    Urol Int. 2017 Jun 14. doi: 10.1159/000477131.
    PubMed     Text format     Abstract available


    May 2017
  26. PORCARO AB, De Luyk N, Corsi P, Sebben M, et al
    Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer.
    Urol Int. 2017 May 10. doi: 10.1159/000476039.
    PubMed     Text format     Abstract available


    April 2017
  27. CHOI H, Cho S, Bae JH, Lee SE, et al
    Characteristics of Prostate Cancer by Opportunistic Screening in Korean Men with a Prostate-Specific Antigen Level Less Than 4.0 ng per Milliliter.
    Urol Int. 2017 Apr 11. doi: 10.1159/000454886.
    PubMed     Text format     Abstract available


    February 2017
  28. MOSCHINI M, Shariat SF, Freschi M, Soria F, et al
    Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2017 Feb 1. doi: 10.1159/000454736.
    PubMed     Text format     Abstract available


    January 2017
  29. ORBERGER M, Palisaar J, Roghmann F, Mittelstadt L, et al
    Association between the Surgical Apgar Score and Perioperative Complications after Radical Prostatectomy.
    Urol Int. 2017;98:61-70.
    PubMed     Text format     Abstract available


  30. KLEIN J, de Gorski A, Benamran D, Vallee JP, et al
    Transrectal Ultrasound-Guided Prostate Biopsy for Cancer Detection: Performance of 2D-, 3D- and 3D-MRI Fusion Targeted Techniques.
    Urol Int. 2017;98:7-14.
    PubMed     Text format     Abstract available


  31. HAAS M, Gunzel K, Miller K, Hamm B, et al
    Is the Ellipsoid Formula the New Standard for 3-Tesla MRI Prostate Volume Calculation without Endorectal Coil?
    Urol Int. 2017;98:49-53.
    PubMed     Text format     Abstract available


  32. GUNZEL K, Haas M, Maxeiner A, Stephan C, et al
    Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
    Urol Int. 2017;98:15-21.
    PubMed     Text format     Abstract available


  33. SCHIFFMANN J, Larcher A, Sun M, Tian Z, et al
    Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database.
    Urol Int. 2017;98:40-48.
    PubMed     Text format     Abstract available


  34. MENDEZ-RUBIO S, Salinas Casado J, Virseda Chamorro M, Gutierrez Martin P, et al
    Post Pelvic Radiotherapy Affectation of the Lower Urinary Tract Peripheral Innervation in Men.
    Urol Int. 2017;98:85-88.
    PubMed     Text format     Abstract available


  35. FOCARDI M, Bonelli A, Pinchi V, Vittori G, et al
    Hemidiaphragm Paralysis after Robotic Prostatectomy: Medical Malpractice or Unforeseeable Event?
    Urol Int. 2017;98:241-244.
    PubMed     Text format     Abstract available


  36. HIRASAWA Y, Yoshioka K, Nasu Y, Yamamoto M, et al
    Impact of Surgeon and Hospital Volume on the Safety of Robot-Assisted Radical Prostatectomy: A Multi-Institutional Study Based on a National Database.
    Urol Int. 2017;98:334-342.
    PubMed     Text format     Abstract available


  37. PEETERS C, Ponette D, van Poppel H
    Salvage Pelvic Lymph Node Dissection after Radical Prostatectomy for Biochemical and Lymph Node Recurrence.
    Urol Int. 2017;98:367-369.
    PubMed     Text format     Abstract available


  38. LAI P, Luo M, Hu G, Liu H, et al
    Primary Urothelial Carcinoma of the Prostate with Glandular Differentiation: A Case Report.
    Urol Int. 2017;98:370-372.
    PubMed     Text format     Abstract available


    January 2016
  39. SARKAR D, Ekwueme K, Parr N
    Patient-Reported Experience of Modified Transperineal Template Guided Saturation Biopsy Under General Anaesthesia and without Prophylactic Catheterisation.
    Urol Int. 2016;96:479-83.
    PubMed     Text format     Abstract available


  40. ANGULO JC, Lopez JI, Dorado JF, Sanchez-Chapado M, et al
    A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy.
    Urol Int. 2016;97:16-25.
    PubMed     Text format     Abstract available


  41. ROSENKRANTZ AB, Lepor H, Huang WC, Taneja SS, et al
    Practical Barriers to Obtaining Pre-Biopsy Prostate MRI: Assessment in Over 1,500 Consecutive Men Undergoing Prostate Biopsy in a Single Urologic Practice.
    Urol Int. 2016;97:247-8.
    PubMed     Text format    


  42. SCHIFFMANN J, Haese A, Lenz J, Heinzer H, et al
    Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume Center.
    Urol Int. 2016;97:8-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: